Please assess the completion status of the following clinical trial:

Trial Title: The Effect of Mifepristone on the Expression of Cervical Prostaglandin EP3 Receptors

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: BASIC_SCIENCE
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* good general health~* ≥18 years old~* seeking termination of a viable intrauterine pregnancy of ≤63 days, without any evidence of a threatened or spontaneous abortion~Exclusion Criteria:~* medical problems~* confirmed or suspected ectopic pregnancy~* having taken medications in the seven days prior to enrollment that would affect PG synthesis or metabolism of mifepristone

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Mifepristone (Type: EXPERIMENTAL): None
- Non-treatment (Type: ACTIVE_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).